𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Nonalcoholic fatty liver disease and liver transplantation

✍ Scribed by Paul Angulo

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
229 KB
Volume
12
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.

✦ Synopsis

Nonalcoholic fatty liver disease affects a substantial proportion of the general population worldwide. This high prevalence of nonalcoholic fatty liver disease has important consequences in the donor selection process for liver transplantation, and in the posttransplant period given the high recurrence rate of disease. This paper reviews the prevalence of nonalcoholic fatty liver disease, its progressive potential, and the implications of this liver condition in both the pre-and post-liver transplantation setting.

πŸ“œ SIMILAR VOLUMES

Nonalcoholic fatty liver disease after l
Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease
✍ Kanthi Yalamanchili; Sherif Saadeh; GΓΆran B. Klintmalm; Linda W. Jennings; Gary πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 262 KB

Nonalcoholic steatohepatitis (NASH) may account for many cases of cryptogenic cirrhosis. If so, then steatosis might recur after liver transplantation. Two thousand fifty-two patients underwent primary liver transplantation for chronic liver disease between 1986 and 2004. Serial liver biopsy samples

De novo nonalcoholic fatty liver disease
De novo nonalcoholic fatty liver disease after liver transplantation
✍ Suk Seo; Kalyani Maganti; Manjit Khehra; Rajendra Ramsamooj; Alexander Tsodikov; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 79 KB

Hepatic steatosis is a recognized problem in patients after orthotopic liver transplant (OLT). However, de novo development of nonalcoholic fatty liver disease (NAFLD) has not been well described. The aim of this study was to determine the prevalence and predictors of de novo NAFLD after OLT. A retr

De Novo nonalcoholic fatty liver disease
De Novo nonalcoholic fatty liver disease after liver transplantation
✍ Manal F. Abdelmalek; Anna Mae Diehl πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 64 KB

Achieving long-term graft survival and mortality is the primary goal of liver transplantation (LT). However, disease recurrence remains a stumbling block, especially among patients with hepatitis C. In such patients, worse outcomes may be associated with comorbidities (i.e., hyperlipidemia, hyperten

Recurrent familial hypobetalipoproteinem
Recurrent familial hypobetalipoproteinemia–induced nonalcoholic fatty liver disease after living donor liver transplantation
✍ Noboru Harada; Yuji Soejima; Akinobu Taketomi; Tomoharu Yoshizumi; Hideaki Uchiy πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 170 KB

Familial hypobetalipoproteinemia (FHBL) is one of the causes of nonalcoholic steatohepatitis (NASH) and a codominant disorder. Patients heterozygous for FHBL may be asymptomatic, although they demonstrate low plasma levels of low-density lipoprotein (LDL) cholesterol and apolipoprotein B. Here we re

Rapid recurrence of nonalcoholic fatty l
Rapid recurrence of nonalcoholic fatty liver disease after transplantation in a child with hypopituitarism and hepatopulmonary syndrome
✍ Maureen M. Jonas; Laura E. Krawczuk; Heung Bae Kim; Craig Lillehei; Antonio Pere πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 248 KB

Nonalcoholic fatty liver disease (NAFLD) has been reported in adults with hypothalamic or pituitary dysfunction, and some have progressed to end stage liver disease requiring transplantation. We report a teenager who initially presented with hypoxia due to intrapulmonary shunting, found to have NAFL